Top 5 Risers
|
Stock |
Rating |
Analysis |
CLMT |
STRONGBUY |
The projected value for Calumet is still rising quickly even though past earnings have already improved significantly. |
UTHR |
STRONGBUY |
An increasingly attractive expected long term growth rate and a significantly higher projected valuation from just a few weeks ago make United Therapeutics a company to watch. |
KKD |
STRONGBUY |
Krispy Kreme is gaining higher expectations and its recent history of its earnings increases is significant. |
EGHT |
BUY |
The long term projected growth rate for 8×8 is rising, and this is happenening at a time when historical earnings have already increased significantly. |
CRNT |
STRONGBUY |
The recent earnings history for Ceragon shows significant improvement while projected valuation continues to rise. |